Search

Author/Creator Stein, Anthony

3. Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML). Issue 13 (10th November 2022)

Authors:
Ball, Brian J.; Arslan, Shukaib; Koller, Paul; Ngo, Dat; Afkhami, Michelle; Salhotra, Amandeep; Al-Malki, Monzr; Aribi, Ahmed; Ali, Haris; Sandhu, Karamjeet; Otoukesh, Salman; Amanam, Idoroenyi; Pourhassan, Hoda; Artz, Andrew; Curtin, Peter; Stein, Anthony; Nakamura, Ryotaro; Marcucci, Guido; Smi...
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 13(2022)
Page Start:
3232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective. (2nd September 2017)

Authors:
Delea, Thomas E.; Amdahl, Jordan; Boyko, Diana; Hagiwara, May; Zimmerman, Zachary F.; Franklin, Janet L.; Cong, Ze; Hechmati, Guy; Stein, Anthony
Journal:
Journal of medical economics
Issue:
Volume 20:Number 9(2017)
Page Start:
911
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia. Issue 11 (18th September 2020)

Authors:
Gökbuget, Nicola; Zugmaier, Gerhard; Dombret, Hervé; Stein, Anthony; Bonifacio, Massimiliano; Graux, Carlos; Faul, Christoph; Brüggemann, Monika; Taylor, Kate; Mergen, Noemi; Reichle, Albrecht; Horst, Heinz-August; Havelange, Violaine; Topp, Max S.; Bargou, Ralf C.
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 11(2020)
Page Start:
2665
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. (November 2022)

Authors:
Bewersdorf, Jan Philipp; Shallis, Rory M.; Derkach, Andriy; Goldberg, Aaron D.; Stein, Anthony; Stein, Eytan M.; Marcucci, Guido; Zeidan, Amer M.; Shimony, Shai; DeAngelo, Daniel J.; Stone, Richard M.; Aldoss, Ibrahim; Ball, Brian J.; Stahl, Maximilian
Journal:
Leukemia research
Issue:
Volume 122(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia. Issue 5 (11th February 2022)

Authors:
Pourhassan, Hoda; Yang, Dongyun; Afkhami, Michelle; Pillai, Raju; Ball, Brian; Al Malki, Monzr; Salhotra, Amandeep; Ali, Haris; Artz, Andrew; Curtin, Peter; Armenian, Saro; Stein, Anthony; Forman, Stephen J.; Marcucci, Guido; Pullarkat, Vinod; Nakamura, Ryotaro; Aldoss, Ibrahim
Journal:
American journal of hematology
Issue:
Volume 97:Issue 5(2022)
Page Start:
E171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation. (December 2019)

Authors:
Nakamura, Ryotaro; Gendzekhadze, Ketevan; Palmer, Joycelynne; Tsai, Ni-Chun; Mokhtari, Sally; Forman, Stephen J.; Zaia, John A.; Senitzer, David; Marcucci, Guido; Stein, Anthony
Journal:
Leukemia research
Issue:
Volume 87(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗